Overview

Evaluation of the Luteolytic Effect of a Gonadotropin Releasing Hormone (GnRH) Agonist After the Administration of Human Chorionic Gonadotropin (hCG) in the Initial Follicular Phase a Its Influence on the Prognosis of in Vitro Fertilization Treatmen

Status:
Unknown status

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

This study was designed to evaluate the ability of gonadotropin releasing hormone (GnRh) agonist to prevent the rise of progesterone during controlled ovarian stimulation for in vitro fertilization (IVF) after the administration of human Chorionic Gonadotropin (hCG) on the first day of menses.

Phase:

Phase 3

Details

Lead Sponsor:

University of Sao Paulo

Treatments:

Chorionic Gonadotropin
Deslorelin
Goserelin
Hormones
Luteolytic Agents
Triptorelin Pamoate